Latest News:- Endocrinology Drugs Market: Diabetes drugs is expected to lead the Therapy Area segment during 2024-2028

Endocrinology Drugs Market to grow at a CAGR of 7.45% during 2024-2028

The Endocrinology Drugs Market is expected to grow at a CAGR of 7.45% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 36837.1 million. The rising prevalence of obesity is linked to an increased incidence of endocrine disorders, including diabetes, hypothyroidism, and polycystic ovary syndrome (PCOS). Obesity may also be a manifestation or secondary effect of less common endocrine disorders such as Cushing's syndrome and hypothyroidism. Effective management of these disorders often involves weight loss strategies. Endocrine disorders associated with obesity can lead to hormonal imbalances, impacting growth hormone levels, testosterone deficiency, and other endogenous hormonal systems. 

Get more information on Endocrinology Drugs Market by requesting a sample report

The Diabetes drugs subsegment is expected to dominate the Therapy Area segment during the forecast period 

Technavio analysts predict that the Diabetes drugs subsegment will lead the Therapy Area segment during 2024 and 2028 The Endocrinology Drugs Market represents a significant business opportunity, driven by the rising prevalence of endocrine disorders and increasing demand for effective treatments. Key players in this market are investing in research and development to launch innovative therapies, while strategic collaborations and mergers and acquisitions are shaping the competitive landscape. Growth is expected to continue, fueled by expanding indications and increasing healthcare expenditure.

Here are the various ways based on which the market is segmented: 

• Therapy Area
  • Diabetes drugs
  • hGH
  • Thyroid hormone disorders
  • Others
• Distribution Channel
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
• Geography
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

Reasons to Purchase the Global Endocrinology Drugs Market Market Research Report by Technavio. What is in it for you?

• Wealth of Experience: Technavio is an established name in the world of market research. It holds an expertise of more than 20 years in the field, has published 21,000+ reports thereby extensively covering the area in various industries and range of regions
• Insight into Current Market Trends: Our research reports provide our readers insights into the latest market intelligence, competitor strategies, market trends, changes taking place in the industry and customer preferences, forecasted market opportunities that influence them to make better business decisions
• High ROI with Extensive Hands-on Research: Technavio is renowned for offering personalized market research reports as per unique business needs, delving deep into specific markets, product segments and demographics. Additionally, it is also well-known for providing high return on investments through its wide collection of data at pocket-friendly rates

There are several factors that are causing the market to flourish increase in incidence of endocrine disorders

Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report

Research Analysis Overview

The Endocrinology Drugs Market encompasses a wide range of medications used to treat various conditions related to the endocrine system. This system is responsible for producing and regulating hormones, which are essential for metabolism, growth, development, and homeostasis. Some common endocrine disorders include Type 2 diabetes, hypothyroidism, hyperthyroidism, and hormonal imbalances. Medications such as Metformin, Pioglitazone, and Teneligliptin are commonly used to manage Type 2 diabetes. Metformin works by decreasing glucose production in the liver, while Pioglitazone and Teneligliptin help improve insulin sensitivity. Levothyroxine Sodium Injection is used to treat hypothyroidism, a condition characterized by underactive thyroid glands. Hormonal imbalances can also affect the reproductive system, leading to conditions like polycystic ovary syndrome (PCOS). Medications like Clomiphene Citrate are used to stimulate ovulation in women with PCOS. Work stress, unhealthy lifestyle characteristics, and obesity can lead to hormonal imbalances and conditions like cholesterol disorders. Endocrinologists specialize in diagnosing and treating these conditions using various medications, including peptides and proteins, steroids, and amines. The endocrine system includes hormone-producing glands such as the hypothalamus, pituitary, ovaries, testes, adrenals, parathyroid, thyroid, and pancreas.

Market Research Overview

The Endocrinology Drugs Market is a significant segment of the larger global pharmaceuticals industry, encompassing companies involved in the research and development (R&D) or production of various offerings, including generic and non-generic medications, as well as veterinary drugs. According to Technavio's market analysis, the healthcare sector's overall size is determined by the consolidated revenue generated by manufacturers and providers of medical equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The pharmaceuticals market expansion will be fueled by several key factors, including the increasing global population aging. By 2050, approximately one-quarter of the US population and, by 2030, a similar ratio in Europe, is projected to be over 60 years old.

The Endocrinology Drugs Market is experiencing significant growth, fueled by the increase in incidence of endocrine disorders. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/